Cargando…

Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction

BACKGROUND: A rising amount of data demonstrates that the epithelial-mesenchymal transition (EMT) in clear cell renal cell carcinomas (ccRCC) is connected with the advancement of the cancer. In order to understand the role of EMT in ccRCC, it is critical to integrate molecules involved in EMT into p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shimiao, Wu, Tao, Ji, Ziliang, Wu, Zhouliang, Lin, Hao, Shen, Chong, Yang, Yinggui, Zheng, Qingyou, Hu, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381281/ https://www.ncbi.nlm.nih.gov/pubmed/35983409 http://dx.doi.org/10.1155/2022/3780391

Ejemplares similares

Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
por: Landolt, Lea, et al.
Publicado: (2017)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells
por: CAO, JIAN, et al.
Publicado: (2016)

Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
por: Mlcochova, Hana, et al.
Publicado: (2016)

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal
por: Wei, Haotian, et al.
Publicado: (2023)

FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition
por: Yang, Chen, et al.
Publicado: (2020)

AB188. Vasohibin-1 and microvessel density predict prognosis in clear cell renal cell carcinoma
por: Tian, Hao, et al.
Publicado: (2016)

Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition
por: Yuan, ChangFei, et al.
Publicado: (2020)

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2019)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023)

Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)

The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-Mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma
por: O'Mahony, Fiach C., et al.
Publicado: (2012)

Deep Learning–Based Classification of Epithelial–Mesenchymal Transition for Predicting Response to Therapy in Clear Cell Renal Cell Carcinoma
por: Chen, Qiwei, et al.
Publicado: (2022)

In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma
por: Sharma, Revati, et al.
Publicado: (2023)

SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition
por: Zhou, Qingqing, et al.
Publicado: (2021)

Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial–mesenchymal transition in clear-cell renal cell carcinoma
por: Yang, Ruo-Nan, et al.
Publicado: (2022)

RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition
por: Shao, I‐Hung, et al.
Publicado: (2023)

Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma
por: Shen, Yuanhao, et al.
Publicado: (2022)

A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma
por: Wang, Yonggang, et al.
Publicado: (2018)

A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma
por: Wang, Yonggang, et al.
Publicado: (2019)

Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition
por: Sun, Guoliang, et al.
Publicado: (2021)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Telmisartan Attenuates Uric Acid-Induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
por: Zha, Dongqing, et al.
Publicado: (2019)

Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma
por: Gui, Ziwei, et al.
Publicado: (2023)

Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial–mesenchymal transition
por: Sun, Guoliang, et al.
Publicado: (2022)

Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
por: Tang, Yunliang, et al.
Publicado: (2020)

AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells
por: Yoshinaga, Tomoyo, et al.
Publicado: (2016)

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)

PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
por: Zhao, Bin, et al.
Publicado: (2018)

lncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-Induced Epithelial-Mesenchymal Transition
por: Wang, Peng, et al.
Publicado: (2020)

MiR-146b-5p/SEMA3G regulates epithelial-mesenchymal transition in clear cell renal cell carcinoma
por: Tang, Mengxi, et al.
Publicado: (2023)

MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma
por: Meng, Longxiyu, et al.
Publicado: (2023)

miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
por: Ran, LongJiao, et al.
Publicado: (2017)

DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
por: Weygant, Nathaniel, et al.
Publicado: (2014)

Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma
por: Wu, Ding, et al.
Publicado: (2022)

Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma
por: Wang, Yulin, et al.
Publicado: (2022)

Correction to: PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
por: Zhao, Bin, et al.
Publicado: (2021)

Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway
por: Duan, Jiachen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ad7ooobpumprmv3plf1sg3gur6